Off-label use of powerful antipsychotic drugs has come in for plenty of debate in recent years. The expensive, newer-generation “atypicals” have been used to treat dementia, depression, anxiety, post-traumatic stress disorder, dementia, attention-deficit hyperactivity disorder…the list goes on. And all this while the Justice Department was investigating Big Pharma for off-label promotion of the drugs.
If you’re feeling down, don’t rush to your doctor just yet. Many instances of mild depression resolve without intervention. In fact, a new analysis published in the Canadian Medical Association Journal (CMAJ) concludes that routine screening for depression isn’t beneficial or efficient.
The United States and Canada recommend screening for depression by primary care providers, but the United Kingdom says no way! The UK does not recommend screening because of a lack of evidence and ineffective use of scarce health care resources.
In addition, The UK’s National Institute for Health and Clinical Excellence guidelines, cite concerns about high rates of false-positive results (in some cases more than 50 percent), lack of evidence, high costs and resources, and the diversion of resources away from people with serious depression.
Over the last 40 years the Diagnostic and Statistical Manual of Mental Disorders – the bible of the psychiatric professions – has spawned more and more diagnostic categories, “inventing” disorders along the way and radically reducing the range of what can be construed as normal or sane. Meanwhile Big Pharma, feeding its appetite for profits and ours for drugs, has gained an ever greater hold over our mental and emotional lives, medicalising normality.
Universities and colleges must crack down on illicit use of Ritalin and other stimulants, which are not the grade boosters many assume, an editorial in the Canadian Medical Association Journal urges
“Students who think simply popping a pill will improve their grades or give them new-found academic abilities are sorely mistaken,” says the editorial released online on Tuesday.
Students use stimulants like Ritalin and Adderall because they are perceived to boost to academic performance through enhanced attention and alertness. But these supposed benefits are not reality based, but are part of a “pervasive myth,” the CMAJ charges.
Child drugging has been a huge profitable market for Big Pharma, earning them $4.8 billion dollars a year. They have done everything in their power to convince the press, legislators and especially parents why children need to be put on drugs. They claim that ADD/ADHD, depression, bipolar disorder, etc., are medical conditions, and consider them on par with cancer, diabetes, and heart disease. But in reality there is no actual evidence that proves that psychiatric disorders are indeed medical conditions. They simply diagnose a child by using a behavioral checklist.
There are 20 million children in the United States who have been diagnosed with some kind of psychiatric disorder and drugged for it. It’s practically an epidemic. Innocent children are being turned into patients for simply acting like kids.